Multiplikator Forward P/S: AVITA Medical (RCEL)
AVITA Medical, Inc. (RCEL) relies on external component suppliers while managing the final assembly of Recell systems. Growth is driven by the implementation of automation in clinics and new methods for scar treatment. Stable management is confidently steering the company toward net profit. The company's forward P/S dynamics reflect market expectations, with the 5.90 mark indicating the current valuation level of capitalization relative to projected revenue.
Ringkesan rincian data analitis AVITA Medical Inc (RCEL)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal AVITA Medical, Inc.|RCEL - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal AVITA Medical, Inc.|RCEL - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku AVITA Medical Inc|RCEL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan AVITA Medical|Rasio cepet avitamedical.com
- rincian asil keuangan lan kelipatan valuasi:
RCEL - Penghasilan resik perusahaan|Bathi sing dikarepake AVITA Medical, Inc.|RCEL - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi AVITA Medical, Inc|RCEL - Pangali PEG|Pangali EV/EBITDA AVITA Medical Inc|RCEL - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan AVITA Medical|RCEL - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan avitamedical.com|RCEL - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep AVITA Medical, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:RCEL (AVITA Medical)
This indicator is calculated as the ratio of the current market value of AVITA Medical, Inc. (RCEL) to projected sales volume, allowing for an assessment of the business value relative to future cash flows. The trend in the expected price-to-sales ratio reflects market optimism as the medical indications for the AVITA Medical system expand, transforming the company's narrow niche specialization into large-scale market potential.
Karo sapa AVITA Medical, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|profusa.com (PFSA) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan SSKN|Rasio rega marang prakiraan pendapatan GCTK|Multiplikator Forward P/S NAOV|Rasio kapitalisasi marang dodolan sing dikarepake Venus Concept Corporation|Nuwellis, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake AEMD (aethlonmedical.com)|TransEnterix - Multiplikator Forward P/S|AVGR - Multiplikator Forward P/S|BSGM (BioSig Technologies, Inc) - Multiplikator forward rega marang pendapatan|Cutera Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Know Labs, Inc.|Multiplikator forward rega marang pendapatan inarimedical.com (NARI)|Multiplikator Forward P/S NVRO|RSLS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
